Important 2020 Patent Law Decisions from the Court of Appeals for the Federal Circuit

Harris Beach PLLC
Contact

Whether you are pursuing patents on your new technology, thinking about bringing patent infringement litigation or defending patent infringement claims in court, knowing the important developments in patent law will help you formulate strategy and can spark a change in your procedures or decision-making process. Laura Smalley, partner with our Intellectual Property Law group, summarizes key judicial holdings in patent law from the Federal Circuit during 2020.

Skinny Label Does Not Prevent Claim of Induced Infringement - Rehearing en banc granted February 9, 2021 -

Carvedilol, marketed by GlaxoSmithKline with the brand name Coreg®, was initially approved by the FDA for the treatment of hypertension. The FDA eventually approved three indications for carvedilol: hypertension, left ventricular dysfunction following a myocardial infarction, and congestive heart failure. After the patent on carvedilol expired on March 5, 2007, the only use covered by a patent was for the treatment of congestive heart failure.

Please see full Insight below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Harris Beach PLLC | Attorney Advertising

Written by:

Harris Beach PLLC
Contact
more
less

Harris Beach PLLC on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.